Nuria Margalef-Mulet

Badalona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy.

Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 07, 2026

Impact of treatment discontinuation among patients with microsatellite instability or mismatch repair-deficient metastatic colorectal cancer treated with immune checkpoint inhibitors.

Impact of treatment discontinuation among patients with microsatellite instability or mismatch repair-deficient metastatic colorectal cancer treated with immune checkpoint inhibitors.

Journal: ESMO open

Published: December 23, 2025

Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapy.

Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapy.

Journal: Gut

Published: August 25, 2025

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.

Journal: JAMA oncology

Published: July 10, 2025

Editorial: Advances in the microbiome, immunity and cancer interplay.

Editorial: Advances in the microbiome, immunity and cancer interplay.

Journal: Frontiers in cellular and infection microbiology

Published: January 30, 2025

Microbiome as a predictive biomarker in locally advanced rectal cancer.

Microbiome as a predictive biomarker in locally advanced rectal cancer.

Journal: Microbiome research reports

Published: November 27, 2024

Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment.

Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 04, 2024

Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape.

Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape.

Journal: Cancers

Published: December 26, 2022

Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer centre network.

Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer centre network.

Journal: Molecular oncology

Published: December 02, 2022

A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy.

A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy.

Journal: International journal of molecular sciences

Published: October 19, 2022

Meta-Analysis and Validation of a Colorectal Cancer Risk Prediction Model Using Deep Sequenced Fecal Metagenomes.

Meta-Analysis and Validation of a Colorectal Cancer Risk Prediction Model Using Deep Sequenced Fecal Metagenomes.

Journal: Cancers

Published: August 05, 2022

Tumor-Associated Microbiome: Where Do We Stand?

Tumor-Associated Microbiome: Where Do We Stand?

Journal: International journal of molecular sciences

Published: January 09, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026